Özer Etik, Diğdem <br/><br/>
Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.  [electronic resource] 

 -  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation  02 2019 
 - 52-58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2146-8427 
<br/><br/><label>Standard No.: </label>10.6002/ect.2018.0095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adult<br/>Aged<br/>Anilides--adverse effects<br/>Antiviral Agents--adverse effects<br/>Carbamates--adverse effects<br/>Cyclopropanes<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Failure, Chronic--complications<br/>Kidney Transplantation--adverse effects<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--adverse effects<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Prospective Studies<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Risk Factors<br/>Ritonavir--adverse effects<br/>Sulfonamides--adverse effects<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Uracil--adverse effects<br/>Valine